MediFransk ApS: Financial statements 2025
CVR: 40780904
Source: annual report 2025, Danish Business Authority
01/01/2025 – 31/12/2025
MediFransk ApS (CVR 40780904) has filed annual accounts for 2025. In 2025, the company reported a gross profit of DKK 485,515 and a net result of DKK 104,261 compared with DKK 50,715 the year before. That is a decrease of 39.8% compared with the year before. Equity in the 2025 report amounted to DKK 174,291. The solvency ratio was 53%.
- Gross Profit
- DKK 485,515
- Profit/Loss
- DKK 104,261
- Equity
- DKK 174,291
- Total Assets
- DKK 328,998
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2025 | - | 486 t. | 104 t. | 174 t. | - |
| 2024 | - | 807 t. | 51 t. | 70 t. | - |
| 2023 | - | 408 t. | -14 t. | 19 t. | - |
| 2022 | - | 608 t. | -9 t. | 33 t. | - |
| 2021 | - | 457 t. | 2 t. | 42 t. | - |
Official annual report
How creditworthy is MediFransk ApS?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2025
MediFransk ApS has published its annual report for 2024. Gross profit came to DKK 806,939, and the net result was DKK 50,715.
About MediFransk ApS
MediFransk ApS is a Danish company of the type Anpartsselskab based in Ålsgårde, founded in 2019. The company is registered under the industry Virksomhedsrådgivning og anden ledelsesrådgivning. The management consists of Frédéric Pierre Louis Bernard. The company is owned by BERNARD Holding ApS. The company has 1 employee (2026). In 2025, the company reported a gross profit of DKK 485,515 and a net result of DKK 104,261 compared with DKK 50,715 the year before. Equity in the 2025 report amounted to DKK 174,291.